Bank of New York Mellon Corp - COCRYSTAL PHARMA INC ownership

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of COCRYSTAL PHARMA INC
ValueSharesWeighting
Q3 2022$13,000
-27.8%
44,5230.0%0.00%
Q2 2022$18,000
-25.0%
44,5230.0%0.00%
Q1 2022$24,000
-17.2%
44,523
+0.0%
0.00%
Q4 2021$29,000
-38.3%
44,5220.0%0.00%
Q3 2021$47,000
-16.1%
44,5220.0%0.00%
Q2 2021$56,000
-9.7%
44,5220.0%0.00%
Q1 2021$62,000
-7.5%
44,522
-9.8%
0.00%
Q4 2020$67,00049,3460.00%
Other shareholders
COCRYSTAL PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 6,110,657$7,638,0001.08%
Altium Capital Management LP 776,000$970,0000.22%
Alyeska Investment Group, L.P. 2,750,100$3,438,0000.04%
Virtu Financial LLC 116,625$146,0000.01%
Parallel Advisors, LLC 184,708$231,0000.01%
Renaissance Technologies 2,593,933$3,242,0000.00%
CIM, LLC 11,000$12,0000.00%
Western Wealth Management, LLC 19,115$24,0000.00%
Mariner, LLC 200,055$250,0000.00%
BRIGHTON JONES LLC 36,000$45,0000.00%
View complete list of COCRYSTAL PHARMA INC shareholders